2002
New Stabilizer Systems Designed to Make Procedure Available to More Patients Brussels, Belgium and Mainz, Germany - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Company to Host Webcast/Conference Call Today Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today reported preliminary results of...
Clinical Trial Fully Enrolled In Less Than Four Months Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it has...
Innovative Lead Instrumental in Delivering Therapy for Heart Failure Patients Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today issued the following statement on the status of its international ACTION...
New Stabilizer Systems Designed to Make Procedure Available to More Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...
Will Provide Physicians with a Cost-Effective, Non-Invasive Means to Monitor Aneurysm Pressure Indianapolis, Ind., Menlo Park, Calif., and Caesaria, Israel - Guidant Corporation (NYSE and PCX:...
Designed for Ease of Handling Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announces...
Presentation Accessible Via Webcast Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that Ronald W. Dollens,...
ACHIEVE CE Mark Filing Represents Milestone in Guidant's Drug Eluting Stent Efforts Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that the company has filed for CE...
Fourth Quarter sales increased 11%, Net Income and EPS, as adjusted*, grew in excess of 15% Double-digit growth leads to Earnings Per Share of $0.47, as adjusted Indianapolis, IN - Guidant...
Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it will...
Unique System Specially Designed to Allow Less Invasive Procedure for Significantly More Patients Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world...
Company Named To Prestigious Ranking For Third Time in Four Years Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular disease, today...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, will conduct a live webcast of its fourth quarter 2001...
System Specially Designed to Allow Less Invasive Procedure for Significantly More Patients Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Company Maintains Optimism as it Continues to Advance Drug-Eluting Stent and Heart Failure Programs Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX:...
Committee to Advise Government on Medicare and Medicaid Reform Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today...
Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it will...